Indegene Limited (BOM:544172)

Market Cap	138.56B
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	29.12
Dividend	2.00 (0.36%)
Ex-Dividend Date	Jun 13, 2025

Volume	247,275
Average Volume	29,778
Open	557.15
Previous Close	543.80
Day's Range	557.15 - 584.80
52-Week Range	485.15 - 736.60
Beta	n/a
RSI	56.04
Earnings Date	Jul 30, 2025

About SolarWinds

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Commercial Physical and Biological Research
• Founded: 1998
• Employees: 4,158
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544172

Financial Performance

In 2025, Indegene's revenue was 29.46 billion, an increase of 3.75% compared to the previous year's 28.39 billion. Earnings were 4.35 billion, an increase of 7.06%.